Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-16-012634

CEO and Interim CFO bought 10,000 shares at an average $2.02 ($20,180)

From the SEC's structured data for this filing

Trades in this filing

DAVE KAUSHIK J · CEO and Interim CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-04-14 Purchase : show line 1 in the form +8,000 $2.02 $16,160 86,500 D
2016-04-14 Purchase : show line 2 in the form +2,000 $2.01 $4,020 88,500 D
Open-market purchases · 10,000 sh · avg $2.02 · $20,180

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-04-15 Grant or award : show line 3 in the form Options to purchase common stock +400,000 $1.99 $796,000 400,000 D
Loading xslF345X03/f4041416dave_actiniumpharm.xml…